With ongoing clinical trials using human pluripotent stem cells (hPSCs), there is a need for rapid and controlled expansion of the cells to meet demand. Current approaches towards scalable hPSC culture use undefined animal products or expensive human-based proteins. Additionally, these products don’t support single-cell culture – which is necessary for large scale biomanufacturing – and result in only about 30 percent cell survival. Unlike these traditional substrates, VitaCapsule is low cost, free of animal products, and supports single cell viability in both planar (2D) and suspension (3D) culture.
